Search Results

Alex Serafini shares why pain research must start with real-world behavior and models before drilling pain research at Hopkins and later an MD-PhD at Mount Sinai. He points out that GPCRs—especially orphan and CNS-associated ones—are often downplayed in pain research Pivoting: Redefining the Pain Research Playbook Looking ahead, Serafini’s vision is bold: build a lab That top-down approach, though less common, could help pain research finally catch up with the complexity

published seminal papers where he used various approaches to describe the role of opioid receptors in pain Dr Gendron is co-director of the FRQS-funded Quebec Pain Research Network and the Editor-in-Chief in

At the end of 2023, I joined the research group of Dr. Nigel Bunnett at the NYU Pain Research Center as a postdoctoral researcher. and chronic pain. Next Steps Badr will continue focusing his research on GPCRs involved in pain and inflammation during , and how his PhD research on non-canonical GPCR roles laid the foundation for his postdoc work.

New research shows that βCGRP triggers distinct receptor signaling profiles across the CGRP receptor This could reshape how we understand CGRP-related physiology—and how we target it in drug design. 🧠 Pain New research shows that βCGRP triggers distinct receptor signaling profiles across the CGRP receptor This could reshape how we understand CGRP-related physiology—and how we target it in drug design. 🧠 Pain

My interests in research are primarily directed towards methods that study GPCRs and GPCR signaling, In my current research project I use iPSC-derived cardiac fibroblasts to examine cellular signaling in GPCR Title: Characterization of Novel Opioid-Neurotensin Bifunctional Ligands Designed to Target Pain interested in characterizing novel G protein-coupled receptors (GPCRs) ligands for the treatment of chronic pain Émile Breault on the web Google Scholar ResearchGate Dr.

Biotech founder Ajay Yekkirala shares how AI, GPCRs, and bold questions are driving next-gen pain therapeutics Learn in This Episode How Ajay’s failed MD/PhD application rerouted his path toward a breakthrough GPCR research career The inside story behind founding Blue Therapeutics and targeting supraspinal pain pathway What , a biotech startup focused on targeting supraspinal GPCRs for chronic pain. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and passion, I recently started a postdoctoral fellowship to study the role of GPCRs in the mechanisms of pain GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the Yamina Berchiche on the web Website LinkedIn Facebook Twitter ResearchGate PubMed Google Scholar Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

for biology and a childhood dream of being an astronaut, he began with intestinal choline transport research Discovering breakthrough results in neuroma pain models via a spontaneous collaboration. Advice for Junior Scientists: Read, Rest, Run Ben closes with wisdom for early-career researchers: “Academia Keyword Cloud GPCR research community , Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

of opioid receptors and is currently focusing on the pharmacology of cannabinoids in the context of pain Graciela Pineyro - CHU Ste-Justine Research Centre Pineyro Lab Publications on Google Scholar Pineyro How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

GPCR is to accelerate GPCR drug discovery by sharing the latest research and technology advances in the Sachdev is an early career researcher in the National Institute of Diabetes and Digestive and Kidney Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors relevant for treating osteoporosis, diabetes, and pain. As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and

Home → Flash News → Can we preserve opioid pain relief without the side effects? GPCR Podcast Can we preserve opioid pain relief without the side effects?

This interest in research and pharmacology took Graciela to Canada where she stayed ever since she arrived characterization of the pharmacological properties of cannabinoids in conjunction with terpenes for pain Graciela Pineyro - CHU Ste-Justine Research Centre Pineyro Lab Publications on Google Scholar Pineyro How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Sachdev is an early career researcher in the National Institute of Diabetes and Digestive and Kidney Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors relevant for treating osteoporosis, diabetes, and pain. Shivani Sachdev on the web NIDDK ReseachGate Google Scholar LinkedIn Twitter Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Grant-funded independent research positions from 2001 at University of Sydney (opioids and sensory neurons ), Vollum Institute Portland (visiting scientist with Ed McCleskey, sensory neuron properties); Pain Management Research Institute (more opioids, cannabinoids and T-type Ca channels) and Brain and Mind Research Institute (Sydney). 2009, appointed Professor of Pharmacology at Macquarie University. Mark Connor on the web Researchers Twitter Google Scholar Dr. GPCR Ecosystem Enjoying the Dr.

Amynah did her undergrad research measuring IP3 in airway smooth muscle cells and completed a Ph.D. at next career step took her to AstraZeneca as a postdoctoral trainee, where she studied animal models of pain How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

Catherine Demery shares how she found clarity and purpose in academic opioid research. building translational experiments, and using real-world data to drive impactful science in the GPCR research Her research combines cutting-edge GPCR signaling studies with real-time public health data from Michigan The role of public health programs in informing lab research. But loss has a way of sharpening focus—friends lost to overdose brought the opioid epidemic into painful

Graeme Milligan Professor Graeme Milligan is Gardiner Professor of Biochemistry, Dean of Research, and His main research group centers on the function, structure, and regulation of G protein-coupled receptors Milligan has published more than 550 peer-reviewed articles and his research has been cited more than Graeme Milligan on the web University of Glasgow ResearchGate PubMed Orcid Google Scholar LinkedIn Dr How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

structural biology, pharmacology, and pharmacoepidemiology with innovative computational methods to gain Alexander had a research sabbatical with Madan Babu at the MRC Laboratory of Molecular Biology in Cambridge He received the “HC Ørsted Research talent prize” and “Bayer Pharmaceuticals Ph.D. Hauser on the web Twitter ResearchGate University of Copenhagen LinkedIn Google Scholar Dr. How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

During his last year of studies, Timo performed research in the biopharmaceutical company Argen X and Raimond Heukers , developed a nanobody platform within the research group and used this platform to develop During his Ph.D., he used these nanobodies as research tools, to investigate different GPCR conformations Starting from September 2019, Timo started working as a postdoctoral researcher at the Vrije Universiteit future, Timo hopes to combine his previous GPCR experience with his current focus to set up his own research

University in Paris and a short internship at Genentech Inc. in South San Francisco, he joined the CNRS as a Research Since 2008, he has arrived at McGill University as a Canada Research Chair. At McGill, his laboratory has two main axes of research: 1) Studying interindividual vulnerability to trainees obtain positions in the academic or private sectors or are currently pursuing postdoctoral research Bruno Giros on the web Dougles Research Center LinkedIn Google Scholar Researchgate Dr.

Beaulieu was an associate professor and Canada Research Chair (Tier2) in the Department of Psychiatry Beaulieu’s research is aimed at understanding how cellular and molecular mechanisms regulated by psychoactive Translational validation is important to validate findings obtained from experimental models research In addition to basic research, the Beaulieu group is also actively implicated in translational research Martin Beaulieu on the web University of Toronto Google Scholar LinkedIn ResearchGate Dr.

Beaulieu was an associate professor and Canada Research Chair (Tier2) in the Department of Psychiatry Beaulieu’s research is aimed at understanding how cellular and molecular mechanisms regulated by psychoactive Translational validation is important to validate findings obtained from experimental models research In addition to basic research, the Beaulieu group is also actively implicated in translational research How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

She returned to Brazil in 2010, when she founded her independent research group. Since then, Dr. Nowadays, her research group comprises four undergraduates, two M.Sc., and six Ph.D. students, as well She was able to have several grants approved in Brazil and abroad, which have granted her research group Ribeiro main scientific contributions include the study of the mechanisms involved in neurodegeneration Fabiola Ribeiro on the web Federal University of Minas Gerais, Brazil Pubmed ResearchGate Instagram Dr

GPCR Podcast Strategic Partners Exploring Career Paths in GPCR Research with Dr. After completing his Ph.D., he pursued research in genetics of metabolic regulation at the Institute of Metabolic Science - Metabolic Research Laboratories at the University of Cambridge in the team led of method development, integrity, and honesty in scientific research. their research interests and achievements, particularly in the field of GPCR.

Learn about Celtarys Research through the Dr. GPCR Ecosystem. Visit Website About Celtarys Research Celtarys Research develops and commercializes new chemical tools Lucía from Celtarys Research Sep 17 4 min read 1 2 3 4 5 Our Partnership Dr. to welcome Celtarys Research to its partner ecosystem. , CEO of Celtarys Research.

Trejo’s research program is to gain a thorough and mechanistic understanding of processes that control Trejo’s research has focused on PAR1, which has important functions in hemostasis, thrombosis, inflammation San Diego Trejo Lab Wikipedia LinkedIn Google Scholar Orcid Twitter UC San Diego School of Medicine Researchgate How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and encompassing neurological and psychiatric disorders, cardiovascular disease, obesity, diabetes, chronic pain Since 2014, Clarivate Analytics have annually named him a Highly Cited Researcher in ‘Pharmacology & GPCR researchers in Australia and the initiation of a successful series of conferences. and its capacity to translate research into therapeutic commercialization.

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and encompassing neurological and psychiatric disorders, cardiovascular disease, obesity, diabetes, chronic pain Since 2014, Clarivate Analytics have annually named him a Highly Cited Researcher in ‘Pharmacology & GPCR researchers in Australia and the initiation of a successful series of conferences. and its capacity to translate research into therapeutic commercialization.

His research focuses on novel paradigms of drug action at GPCRs, particularly allosteric modulation and encompassing neurological and psychiatric disorders, cardiovascular disease, obesity, diabetes, chronic pain Since 2014, Clarivate Analytics have annually named him a Highly Cited Researcher in ‘Pharmacology & Next steps - Arthur will continue to collaborate with other researchers and drug companies to advance The conversation ended with Arthur's ongoing research and his development of a new operational model.

at Cold Spring Harbor Laboratory and probed the roles of polarity proteins (Feigin, et al., Cancer Research Quick recap Yamina and Mike engaged in a conversation about their scientific research experiences. Mike's Research on Cell Polarity and GPCRs in Cancer Mike shared his research on cell polarity and its The conversation ended with Yamina expressing interest in learning more about Mike's two main research Cytokine Inhibition, Collaboration, and Anti-Anxiety Drug Research Mike discussed the ongoing research